These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19804830)

  • 21. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity.
    Kovács AD; Cebers G; Cebere A; Moreira T; Liljequist S
    Exp Neurol; 2001 Mar; 168(1):47-62. PubMed ID: 11170720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
    Gomes CA; Vaz SH; Ribeiro JA; Sebastião AM
    Brain Res; 2006 Oct; 1113(1):129-36. PubMed ID: 16935271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents.
    Guntz E; Dumont H; Pastijn E; d'Exaerde Ade K; Azdad K; Sosnowski M; Schiffmann SN; Gall D
    Anesth Analg; 2008 Jun; 106(6):1882-9. PubMed ID: 18499627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
    Brambilla R; Cottini L; Fumagalli M; Ceruti S; Abbracchio MP
    Glia; 2003 Aug; 43(2):190-4. PubMed ID: 12838511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
    Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
    Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
    Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
    J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
    Dunah AW; Wang Y; Yasuda RP; Kameyama K; Huganir RL; Wolfe BB; Standaert DG
    Mol Pharmacol; 2000 Feb; 57(2):342-52. PubMed ID: 10648644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets.
    Reilmann R; Rolf LH; Lange HW
    Exp Neurol; 1997 Apr; 144(2):416-9. PubMed ID: 9168841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
    André VM; Cepeda C; Venegas A; Gomez Y; Levine MS
    J Neurophysiol; 2006 Apr; 95(4):2108-19. PubMed ID: 16381805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms involved in the adenosine A and A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures.
    Canals M; Angulo E; Casadó V; Canela EI; Mallol J; Viñals F; Staines W; Tinner B; Hillion J; Agnati L; Fuxe K; Ferré S; Lluis C; Franco R
    J Neurochem; 2005 Jan; 92(2):337-48. PubMed ID: 15663481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
    Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
    Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.
    Hansson O; Petersén A; Leist M; Nicotera P; Castilho RF; Brundin P
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8727-32. PubMed ID: 10411943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.
    Fantin M; Morari M; Tison F; Fernagut PO
    Neurol Res; 2011 May; 33(4):444-7. PubMed ID: 21535946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.
    Orrú M; Zanoveli JM; Quiroz C; Nguyen HP; Guitart X; Ferré S
    Exp Neurol; 2011 Nov; 232(1):76-80. PubMed ID: 21867705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model.
    Jarabek BR; Yasuda RP; Wolfe BB
    Brain; 2004 Mar; 127(Pt 3):505-16. PubMed ID: 14662521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.